vs

Side-by-side financial comparison of Dexcom (DXCM) and TFI International Inc. (TFII). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $921.9M, roughly 1.4× TFI International Inc.).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

TFI International Inc. is a Canadian transport and logistics company based in Saint-Laurent, Quebec, a borough of Montreal. It operates primarily in Canada, the United States, and Mexico through 4 business segments: less than truckload (LTL), package and courier, logistics, and truckload. It has Canada's largest LTL business, largest trucking fleet, and in 2021 was ranked 6th in terms of revenue among both LTL and truckload North American carriers. Its trucking fleet consists of over 14,000 c...

DXCM vs TFII — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.4× larger
DXCM
$1.3B
$921.9M
TFII

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
DXCM
DXCM
TFII
TFII
Revenue
$1.3B
$921.9M
Net Profit
$267.3M
Gross Margin
62.9%
Operating Margin
25.6%
8.4%
Net Margin
21.2%
Revenue YoY
21.6%
Net Profit YoY
153.6%
EPS (diluted)
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
TFII
TFII
Q1 26
$1.3B
Q4 25
$1.3B
Q3 25
$1.2B
$921.9M
Q2 25
$1.2B
$2.0B
Q1 25
$1.0B
$2.0B
Q4 24
$1.1B
Q3 24
$994.2M
$1.0B
Q2 24
$1.0B
$2.3B
Net Profit
DXCM
DXCM
TFII
TFII
Q1 26
$267.3M
Q4 25
$267.3M
Q3 25
$283.8M
Q2 25
$179.8M
$98.2M
Q1 25
$105.4M
$56.0M
Q4 24
$151.7M
Q3 24
$134.6M
Q2 24
$143.5M
$117.8M
Gross Margin
DXCM
DXCM
TFII
TFII
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
TFII
TFII
Q1 26
25.6%
Q4 25
25.6%
Q3 25
20.1%
8.4%
Q2 25
18.4%
8.4%
Q1 25
12.9%
5.8%
Q4 24
17.0%
Q3 24
15.3%
9.5%
Q2 24
15.7%
9.2%
Net Margin
DXCM
DXCM
TFII
TFII
Q1 26
21.2%
Q4 25
21.2%
Q3 25
23.5%
Q2 25
15.5%
4.8%
Q1 25
10.2%
2.9%
Q4 24
13.6%
Q3 24
13.5%
Q2 24
14.3%
5.2%
EPS (diluted)
DXCM
DXCM
TFII
TFII
Q1 26
$0.67
Q4 25
$0.67
Q3 25
$0.70
Q2 25
$0.45
Q1 25
$0.27
Q4 24
$0.37
Q3 24
$0.34
Q2 24
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
TFII
TFII
Cash + ST InvestmentsLiquidity on hand
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
Total Assets
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
TFII
TFII
Q1 26
$917.7M
Q4 25
$917.7M
Q3 25
$1.8B
Q2 25
$1.2B
Q1 25
$904.9M
Q4 24
$606.1M
Q3 24
$621.2M
Q2 24
$939.2M
Stockholders' Equity
DXCM
DXCM
TFII
TFII
Q1 26
$2.7B
Q4 25
$2.7B
Q3 25
$2.7B
Q2 25
$2.6B
Q1 25
$2.3B
Q4 24
$2.1B
Q3 24
$2.0B
Q2 24
$2.4B
Total Assets
DXCM
DXCM
TFII
TFII
Q1 26
$6.3B
Q4 25
$6.3B
Q3 25
$7.5B
Q2 25
$7.3B
Q1 25
$6.8B
Q4 24
$6.5B
Q3 24
$6.4B
Q2 24
$6.8B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons